Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation With Rivaroxaban in Post Cardioversion Patients

NCT01747746 is registered in ClinicalTrials.gov with Cook County Health as lead sponsor.

NCT NCT01747746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01747746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation With Rivaroxaban in Post Cardioversion Patients
Lead sponsor
Cook County Health
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
October 31, 2014
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, bleeding, stroke, thrombo-embolism